banner add

A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says

Results of a large clinical trial found the treatment did not work any better than a placebo.

from NYT > Health https://ift.tt/QqZztw7
via IFTTT

No comments

UnitedHealth Group Reports Flat First-Quarter Earnings

One of the nation’s largest insurers, the company’s profits were higher than analysts’ expectations but still fell short of showing a signif...

Theme images by PLAINVIEW. Powered by Blogger.